Feedback
Settings

Settings

1. WO2014026054 - CD20 scFv-ELPs METHODS AND THERAPEUTICS

PermaLink
Publication Number WO/2014/026054
Publication Date 13.02.2014
International Application No. PCT/US2013/054218
International Filing Date 08.08.2013
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
39
Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
A61K 38/39 (2006.01)
A61K 39/00 (2006.01)
A61K 38/17 (2006.01)
CPC
A61K 2039/505
A61K 38/00
A61K 47/6435
A61K 47/6849
A61K 47/6929
A61K 48/005
Applicants
  • UNIVERSITY OF SOUTHERN CALIFORNIA [US/US]; 1150 South Olive Street, Suite 2300 Los Angeles, California 90015, US
Inventors
  • EPSTEIN, Alan, L.; US
  • MACKAY, John Andrew; US
  • HU, Peisheng; US
  • ALURI, Suhaas; US
Agents
  • KONSKI, Antoinette F.; 975 Page Mill Road Palo Alto, California 94304-1013, US
Priority Data
61/682,02910.08.2012US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) CD20 scFv-ELPs METHODS AND THERAPEUTICS
(FR) PROCÉDÉS ET PRODUITS THÉRAPEUTIQUES CD20 SCFV-ELP
front page image
Abstract
(EN)
Disclosed herein are recombinant polypeptides comprising an elastin-like peptide (ELP) and a scFv, or a biological equivalent of the scFv. Also disclosed are compositions containing scFv-ELP polypeptides and methods of use.
(FR)
La présente invention concerne des polypeptides recombinants comprenant un peptide de type élastine (ELP) et un scFv, ou un équivalent biologique du scFv. L'invention concerne également des compositions contenant des polypeptides scFv ELP et leurs procédés d'utilisation.
Also published as
US20150218280
Latest bibliographic data on file with the International Bureau
# -